Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

European approval for Astellas’ first-in-class bladder drug Betmiga

Will compete with Pfizer's Detrol and Astellas' own Vesicare

- PMLiVE

J&J gets FDA panel backing for canagliflozin

Moves ahead of BMS/AZ’s Forxiga in race for US approval as first in new class of diabetes drug

- PMLiVE

FDA lowers recommended dose for sleeping pills

Says insomnia drugs like Ambien could impair ability to drive in morning

- PMLiVE

GSK and Theravance file COPD combo for EU approval

Filing for LAMA/LABA combination comes shortly after US submission

- PMLiVE

Will opportunity knock for eHealth in 2013?

If EC plans succeed, they will transform the way technology is used

Ischemix names David DeWahl as CEO

He joins the US biotech from private investment firm Colchester Healthcare Investments

- PMLiVE

NHS failing to promote clinical trials to patients

NIHR mystery shoppers report says 91 per cent of sites have no information in reception area

- PMLiVE

Royal National Orthopaedic Hospital NHS Trust appoints Grayling

Agency brought in as hospital plans £84m improvement programme

- PMLiVE

Olympic gold medalist becomes face of Asthma UK

Cyclist Laura Trott is supporting the charity’s Facebook page

- PMLiVE

Gilead $1bn antibody deal with MacroGenics

Joins Boehringer and Servier in use of US biotech’s DART technology

- PMLiVE

FDA releases guidance on how to prevent abuse of opioid painkillers

Explains to companies best ways to make tamper-resistant drugs

- PMLiVE

FDA-approved iPhone heart monitor now available

AliveCor's device can initially only be bought by US healthcare professionals

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links